|
Early Learning Interagency Policy Board (IPB)
|
Other
|
ACF
|
NICHD
|
The purpose of this workgroup is to collaborate with the Administration for Children and Families in order to coordinate efforts in the area of preschool education, including research.
|
|
Elder Justice Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACL, IHS
|
NIA
|
The Elder Justice Interagency Working Group was established to protect older adults from abuse including self-neglect. NIA was a founding member of the group along with the Administration on Aging (AoA). The group brings together federal officials responsible for carrying out elder justice activities, including elder abuse prevention, research, grant and program-funding, and prosecutions. Members meet regularly to discuss emerging issues, promising practices, and ways to coordinate their efforts. AoA has also put together a working group to lay the foundation for a study that will determine the prevalence of elder exploitation, and the adequacy of current Federal and State legal protections in this area.
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
OD/OER, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA).
eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and non-research grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting-edge biomedical research via grants to scientists at universities and other research institutions. Over 4,600 NIH staff, 700 partner agency staff, and 166,000 active external users depend on eRA daily.
Used by Federal staff and applicants at over 12,500 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to:
• Record, review and process over 80,000 applications each year.
• Support more than 3,500 review meetings held annually.
• Administer more than 55,000 awarded competing and non-competing grants.
• Maintain patent and invention records for 25 Federal agencies (see the iEdison website).
• Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface.
eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scaleable infrastructure, is responsive to evolving customer needs and employs sound management controls.
eRA systems align with Grants.gov (the one-stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter.
|
|
Emergency Preparedness, medical countermeasures
|
Other
|
OS
|
NCI
|
NCI provides expertise in radiation biology and radiation oncology to help guide the research and development for medical countermeasures for radiation injury and for biomarkers for assessing injury, dose and who needs treatment.
|
|
Endemic and Emerging Infectious Diseases of Priority in the Middle East and North Africa: Research Opportunities and Biosafety in a Changing Environment
|
Meeting/ Workshop
|
CDC
|
NIAID
|
This meeting explored ways to foster Innovative biomedical methodologies and training in biosafety and biosecurity.
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.
|
|
Enhanced Comprehensive HIV Prevention Planning (ECHPP) Cross-Agency Programmatic Workgroup
|
Other
|
CDC, HRSA, IHS, OS
|
NIAID, NIMH
|
The purpose of this group is to enhance federal coordination in support of the National HIV AIDS Strategy, specifically related to the Enhanced Comprehensive HIV/AIDS Prevention Plan funded by the CDC.
|
|
Enhanced Comprehensive HIV Prevention Planning (ECHPP)/12-Cities Initiatives
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, IHS, SAMHSA
|
NIMH, NIAID
|
NIMH staff have participated in workgroups to inform the implementation of the Enhanced Comprehensive HIV Prevention Planning (ECHPP)/HHS Twelve Cities Project. This project is funded by the CDC''s Division of HIV/AIDS Prevention. The project aims to maximize the impact of HIV prevention in the twelve metropolitan areas with the highest AIDS prevalence in the United States.
|
|
Enhancements to the U.S. Life Table Program
|
Research Initiative
|
CDC
|
NIA
|
The objectives of this research project are the enhancement and expansion of the U.S. life table program. This will consist of the production of national life tables by detailed race, Hispanic origin, nativity status, and educational status of the U.S. population.
|
|
Ethical, Legal and Social Issues (ELSI) sub-study in the Biospecimen Pre-Analytical Variables (BPV) project
|
Research Initiative
|
OS
|
NCI, CC
|
This Substudy is part of ongoing efforts by the Cancer Human Biobank (caHUB) program to improve effectiveness and generate best practices for the biospecimen research community. The Biospecimen Pre-Analytical Variables (BPV) Ethical Legal and Social Implications (ELSI) Substudy is a study of the ethical, legal and social implications related to the informed consent process for biobanking. The ELSI study will be designed to address current issues related to informed consent for biobanking, particularly the issue of consent for broad future research use, and will be approached in a two-step fashion.
The objective of the ELSI Substudy is to assess research participant comprehension and concerns related to informed consent for biobanking across the diverse patient populations included in the BPV program. The intent of this evaluation is to improve our understanding of the issues that impact donor participation in such programs and to identify factors that may result in decreased rates of donor participation. This study will provide a unique and unprecedented opportunity to address these issues in a diverse patient population of actual biospecimen contributors approached for consent using a highly harmonized informed consent document. Each Biospecimen Source Site (BSS) collecting tumor tissue from surgical procedures shall ensure participation in the ELSI study.
Both BPV participants and decliners will be surveyed, using two different survey instruments.
|